The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Defining subgroups of patients with intermediate risk prostate cancer for whom active surveillance is safe.
 
Ruben Del Castillo
No Relationships to Disclose
 
Danny Vesprini
Honoraria - Elekta; Merck
Consulting or Advisory Role - AstraZeneca Canada
 
Stanley Liu
No Relationships to Disclose
 
Hon Leong
No Relationships to Disclose
 
Mona Beera
No Relationships to Disclose
 
Zeeba Sadiq
No Relationships to Disclose
 
Liying Zhang
No Relationships to Disclose
 
Alexandre Mamedov
No Relationships to Disclose
 
Meghan Kulasingham-Poon
No Relationships to Disclose
 
Laurence Klotz
Leadership - miR Scientific
Honoraria - Bayer; Exact Imaging; Ferring; Profound Medical
Consulting or Advisory Role - Astellas Pharma
Research Funding - Exact Imaging; Ferring
Patents, Royalties, Other Intellectual Property - KVR Pharma
Travel, Accommodations, Expenses - TerSera
 
Andrew Loblaw
Employment - Sanofi (I)
Stock and Other Ownership Interests - Sanofi (I)
Honoraria - Astellas Pharma; Bayer; Janssen Oncology; Knight Therapeutics; Sumitomo Pharma Oncology; Tersera; Tolmar
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen Oncology; TerSera
Research Funding - Tersera
Patents, Royalties, Other Intellectual Property - Prostate immobilization device (GU-Lok)
Travel, Accommodations, Expenses - Tolmar